Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 1, 2008ThoraxOpen Access

Markers of treatment failure in hospitalised community acquired pneumonia

View Full Paper
Ask AI
Bookmark
Share

Authors

RMRosario MenéndezMCManuela CavalcantiSRS. Reyes

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Menéndez et al. (2008) studied this question.

synapsesocial.com/papers/6a93bbbdb8961b8efcafe2dbhttps://doi.org/10.1136/thx.2007.086785
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Procalcitonin Kinetics as a Prognostic Marker of Ventilator-associated Pneumonia2004 · 288 citations
  2. 2Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults2007 · 6,281 citations
  3. 3Diagnostic Value of Procalcitonin, Interleukin-6, and Interleukin-8 in Critically Ill Patients Admitted with Suspected Sepsis2001 · 910 citations
  4. 4Causes and predictors of nonresponse to treatment of intensive care unit–acquired pneumonia*2004 · 118 citations
  5. 5Severe Community-acquired Pneumonia: Risk Factors and Follow-up Epidemiology1999 · 518 citations